Related Experiment Video

Updated: Dec 31, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.7K

The Potential Role of Lumateperone-Something Borrowed? Something New?

Joshua T Kantrowitz1,2

  • 1Department of Psychiatry, Columbia University, New York, New York.

JAMA Psychiatry
|January 9, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Lumican Extraction from Amniotic Membrane and Determination of its Storage Temperature
04:21

Lumican Extraction from Amniotic Membrane and Determination of its Storage Temperature

Published on: October 14, 2022

1.7K
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on: October 15, 2017

8.7K

Related Experiment Videos

Last Updated: Dec 31, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.7K
Lumican Extraction from Amniotic Membrane and Determination of its Storage Temperature
04:21

Lumican Extraction from Amniotic Membrane and Determination of its Storage Temperature

Published on: October 14, 2022

1.7K
Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
06:14

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on: October 15, 2017

8.7K

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

822
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
822
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

888
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
888

Articles linked to this work by shared authors, journal, and citation graph.

Serotonin type 3 receptor (5-HT3R) antagonists for negative symptoms and cognitive impairment associated with schizophrenia: a systematic review and meta-analysis.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026

A phase 2 randomized controlled trial of luvadaxistat in treatment of adults with cognitive impairment associated with schizophrenia: results from the ERUDITE study.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026

Keep your participants close, but your informants closer? The added value of high and low contact informants to supplement self-report for the cognitive impairment of schizophrenia.

Schizophrenia research. Cognition·2026

A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trial.

Journal of psychiatric research·2026

Effect Size Deflation With Increasing Sample Size in Adjunctive Trials for Negative Symptoms in Schizophrenia: A Meta-Analysis and Meta-Regression Across Mechanisms of Action.

The American journal of psychiatry·2025

Feasibility of a digital therapeutic for experiential negative symptoms of schizophrenia: results from an exploratory study.

Schizophrenia (Heidelberg, Germany)·2025

Trends in the Prevalence and Severity of Alcohol and Cannabis Use Disorders Among US Adults.

JAMA psychiatry·2026

Neural Markers of Reward Valuation and Impulsive Decision-Making in Mania Risk.

JAMA psychiatry·2026

Predicting US Army Soldier Suicide-Related Behaviors at the Time of Periodic Health Assessments.

JAMA psychiatry·2026

Depression and SSRI Treatment During Pregnancy-Prioritizing Maternal Mental Health.

JAMA psychiatry·2026

Psychotherapy for Impact of Killing During War: A Randomized Clinical Trial.

JAMA psychiatry·2026

Optimizing Study Design for Clinically Useful Peripheral Molecular Biomarker Discovery in Psychiatry: A Review.

JAMA psychiatry·2026

Shifting Perceptions of Cosmetic Procedures: Rise of Medical Spas in Online Search Trends.

JMIR dermatology·2026

Magazine 2026/1: Special Edition - Medical Repatriation and TMAS.

International maritime health·2026

Referral of Pediatric Moyamoya for Revascularization: Financial and Quality Data Supporting Private Insurer Approval for Out-of-Network Care.

Stroke (Hoboken, N.J.)·2026

Retraction notice to "Investigation of management of international education considering sustainable medical tourism and entrepreneurship" [Heliyon 9 (2023) e12691].

Heliyon·2025

Implications of U.S. withdrawal from the World Health Organization on health financing in Africa.

Health policy OPEN·2025

Tardive dystonia in Gilles de la Tourette syndrome - a single center experience.

Neurologia i neurochirurgia polska·2025
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us